News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Elutia
NEWS
JOBS
NEWS
FDA
Excessive Impurities Cause Recall of Pfizer’s Anti-Smoking Drug
Pfizer has voluntarily recalled two lots of Chantix 0.5 mg tablets, two lots of Chantix 1 mg tablets, and eight lots of a Chantix kit consisting of 0.5mg/1 mg tablets.
July 20, 2021
·
2 min read
·
Brandon May
Business
Aziyo Biologics Banks Some Cash And Former Osiris Exec As Its New CEO
June 15, 2017
·
1 min read
IN THE PRESS
Press Releases
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th
June 12, 2026
·
2 min read
Press Releases
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - May 18, 2026
May 18, 2026
·
1 min read
Press Releases
Elutia to Present at the 16th Annual LD Micro Invitational on May 18th
May 14, 2026
·
1 min read
Press Releases
Elutia Reports First Quarter 2026 Results and Highlights NXT-41x Progress Toward $1.5 Billion U.S. Plastic and Reconstructive Surgery Market
May 14, 2026
·
14 min read
Press Releases
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
April 30, 2026
·
1 min read
Press Releases
Elutia to Present at Sidoti’s Small-Cap Virtual Investor Conference March 18-19
March 17, 2026
·
2 min read
Press Releases
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - March 13, 2026
March 13, 2026
·
1 min read
Press Releases
Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process
March 12, 2026
·
16 min read
Press Releases
Elutia Regains Compliance with Nasdaq Listing Requirements
March 4, 2026
·
2 min read
Press Releases
Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market
March 2, 2026
·
7 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details